Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Functions of Sodium Bisulfite

Pres - Chemical preservative


Route Formulation Per Unit Dose
An,infiltration Injection 0.2%
Auricular (otic) Solution 0.1%
Auricular (otic) Suspension 0.001%
Epidural Injection
Im - Iv Injection 0.66%
Im - Iv Powder, For Injection Solution 5.18%
Im - Iv Solution, Injection
Im - Iv - Sc Injection 0.5%
Inhalation Inhalant 0.08%
Intra-Arterial Injection
Intra-Articular Injection 0.32%
Intra-Articular Injection, Sustained Action
Intrabursal Injection
Intracardiac Injection 0.1%
Intradermal Injection, Sustained Action
Intradiscal Powder, For Injection Solution
Intralesional Injection 0.32%
Intralesional Injection, Sustained Action
Intramuscular Injection 0.66%
Intramuscular Injection, Sustained Action
Intraperitoneal Injection 0.66%
Intrasynovial Injection 0.32%
Intrasynovial Injection, Sustained Action
Intravenous Injection 1.6%
Intravenous Solution, Injection 0.05%
Iontophoresis Solution 0.06%
Irrigation Injection 0.33%
Iv(infusion) Injection 10%
Iv(infusion) Solution, Injection 0.02%
Nerve Block Injection 2.2%
Ophthalmic Solution 0.1%
Ophthalmic Solution, Drops 0.1%
Ophthalmic Suspension 0.06%
Oral Capsule 0.36MG
Oral Concentrate 0.05%
Oral Solution 0.1%
Oral Suspension 0.04%
Oral Syrup
Oral Tablet 0.65MG
Soft Tissue Injection 0.1%
Subcutaneous Injection 0.15%
Sublingual Tablet 0.5MG
Topical Emulsion, Cream 0.3%
Topical Lotion
Topical Powder, For Solution 0.1%W/V
Topical Solution 0.06%W/V

More Information

Usage Over Time